4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-032438
Chief Financial Officer sold 20,000 shares at an average $32.08 ($641,642)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-11 | Exercise or conversion : show line 1 in the form | +10,000 | $6.55 | $65,500 | 31,604 | D |
| 2021-05-11 | Sale : show line 2 in the form | −2,969 | $30.81 | $91,475 | 28,635 | D |
| 2021-05-11 | Sale : show line 3 in the form | −7,031 | $31.84 | $223,867 | 21,604 | D |
| 2021-05-12 | Exercise or conversion : show line 4 in the form | +10,000 | $6.55 | $65,500 | 31,604 | D |
| 2021-05-12 | Sale : show line 5 in the form | −10,000 | $32.63 | $326,300 | 21,604 | D |
| Open-market sales · 20,000 sh · avg $32.08 · $641,642 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-11 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −10,000 | 140,000 | D |
| 2021-05-12 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −10,000 | 130,000 | D |
Loading xslF345X03/doc4.xml…